← Back to Search

Online Medical Record Access for Breast and Prostate Cancer Screening Recall

N/A
Recruiting
Led By Cheryl Thompson, PhD
Research Sponsored by Case Comprehensive Cancer Center
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Diagnosed with breast or prostate cancer within the last 10 years
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up at 1 week (after second survey completed)
Awards & highlights

Study Summary

This trial is testing if giving extra time or resources to patients helps them remember more details about their cancer screening and care.

Who is the study for?
This trial is for individuals in Northeast Ohio who have been diagnosed with breast or prostate cancer within the last decade and have internet access plus an email. It's not specified who can't join, but typically those not meeting the inclusion criteria would be excluded.Check my eligibility
What is being tested?
The study is examining if providing time or other resources helps people better recall their cancer screening and diagnosis details by using online medical records through patient portals.See study design
What are the potential side effects?
Since this trial involves accessing information online rather than testing a drug, there are no direct physical side effects. However, participants may experience stress or anxiety related to recalling their cancer experiences.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I was diagnosed with breast or prostate cancer in the last 10 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~at 1 week (after second survey completed)
This trial's timeline: 3 weeks for screening, Varies for treatment, and at 1 week (after second survey completed) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Accuracy of survey
Completeness of survey

Trial Design

2Treatment groups
Active Control
Group I: Control GroupActive Control1 Intervention
Survey questions at baseline and at one week. The control group will have had one week to reflect on the questions, and investigators anticipate some influence of this on responses.
Group II: Intervention GroupActive Control1 Intervention
The intervention group will be prompted about accessing their medical records from the major local health systems online, with links to directions provided by each hospital system. They will then be asked to fill out the same questionnaire.

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor
452 Previous Clinical Trials
31,810 Total Patients Enrolled
54 Trials studying Breast Cancer
4,867 Patients Enrolled for Breast Cancer
Cheryl Thompson, PhDPrincipal InvestigatorCase Comprehensive Cancer Center
2 Previous Clinical Trials
2,218 Total Patients Enrolled
2 Trials studying Breast Cancer
2,218 Patients Enrolled for Breast Cancer

Media Library

Intervention Group Clinical Trial Eligibility Overview. Trial Name: NCT05014295 — N/A
Breast Cancer Research Study Groups: Control Group, Intervention Group
Breast Cancer Clinical Trial 2023: Intervention Group Highlights & Side Effects. Trial Name: NCT05014295 — N/A
Intervention Group 2023 Treatment Timeline for Medical Study. Trial Name: NCT05014295 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~67 spots leftby Dec 2024